XORTX Therapeutics (XRTX) FCF Payout Ratio (2023)
XORTX Therapeutics (XRTX) posted FCF Payout Ratio of 1065.54 for Q2 2023, down 136.01% on a QoQ basis from 2958.65 in Q1 2023.
XORTX Therapeutics (XRTX) FCF Payout Ratio (2023) Analysis & Trends
XORTX Therapeutics' FCF Payout Ratio history runs 1 years deep, the most recent figure standing at 1065.54 for Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.12 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | XORTX Therapeutics | 2.91 Bn | 2.91 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -1,065.54 |
| Mar 31, 2023 | 2,958.65 |